Fosinopril with dual clearance can be used in renal failure without dose correction, which may be required in diabetes or elderly patients even with normal creatinine level in blood plasma. Therefore, fosinopril can be indicated as the drug of choice in patients with renal failure and high risk of kidney disease. Fosinopril can be used either as monotherapy or in combination with hydrochlorothiazide, including fixed combinations
Cardiovascular events (CVEs) are the leading cause of death in chronic hemodialysis patients. Result...
Abstract Hypertension has a major associated risk for organ damage and mortality, which is further h...
The kidney is one of the principal target organs of hypertension and most diseases of the kidney are...
This article discusses clinicopharmacological niches of fosinopril, one of the most popular ACE inhi...
The prevalence of congestive heart failure (CHF), a debilitating condition associated with impaired ...
Data regarding the tolerance of ACE inhibitors in old age are sparse, despite this class of compound...
Data regarding the tolerance of ACE inhibitors in old age are sparse, despite this class of compound...
The article exemplified the successful experience of using combination therapy consisting of fosinop...
OBJECTIVE: To investigate in a random comparison the capacity of an angiotensin converting enzyme in...
Objective: evaluate antihypertensive and vasoprotective effects of fosinopril in patients with arter...
Abstract The antihypertensive effect and safety of fosinopril and hydrochlorothiazide combined were ...
Cardiovascular diseases (CVD) remain the main cause of mortality in the world. [1] At the same time,...
Hypertension and kidney disease often coexist, further increasing the risk of future cardiovascular ...
<p>Up-to-date data on combination therapy of arterial hypertension in patients with chronic kidney d...
ACE inhibitors effectively reduce systemic vascular resistance in patients with hypertension, heart ...
Cardiovascular events (CVEs) are the leading cause of death in chronic hemodialysis patients. Result...
Abstract Hypertension has a major associated risk for organ damage and mortality, which is further h...
The kidney is one of the principal target organs of hypertension and most diseases of the kidney are...
This article discusses clinicopharmacological niches of fosinopril, one of the most popular ACE inhi...
The prevalence of congestive heart failure (CHF), a debilitating condition associated with impaired ...
Data regarding the tolerance of ACE inhibitors in old age are sparse, despite this class of compound...
Data regarding the tolerance of ACE inhibitors in old age are sparse, despite this class of compound...
The article exemplified the successful experience of using combination therapy consisting of fosinop...
OBJECTIVE: To investigate in a random comparison the capacity of an angiotensin converting enzyme in...
Objective: evaluate antihypertensive and vasoprotective effects of fosinopril in patients with arter...
Abstract The antihypertensive effect and safety of fosinopril and hydrochlorothiazide combined were ...
Cardiovascular diseases (CVD) remain the main cause of mortality in the world. [1] At the same time,...
Hypertension and kidney disease often coexist, further increasing the risk of future cardiovascular ...
<p>Up-to-date data on combination therapy of arterial hypertension in patients with chronic kidney d...
ACE inhibitors effectively reduce systemic vascular resistance in patients with hypertension, heart ...
Cardiovascular events (CVEs) are the leading cause of death in chronic hemodialysis patients. Result...
Abstract Hypertension has a major associated risk for organ damage and mortality, which is further h...
The kidney is one of the principal target organs of hypertension and most diseases of the kidney are...